Lysophosphatidic acid upregulates laminin-332 expression during a431 cell colony dispersal

Journal of Oncology

Volumn , Issue , 2010, Pages

  Quaranta, Vito ^a   Yamashita, Hironobu ^a   Tripathi, Manisha ^a   Jourquin, Jerome ^a   Kam, Yoonseok ^b   Liu, Shanshan ^a   Weidow, Brandy ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KALININ; LAMININ ALPHA 3; LAMININ BETA 3; LAMININ GAMMA2; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL CONTACT; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

EID: 77957888221     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/107075     Document Type: Article

References (51)

1. van Corven E. J., Groenink A., Jalink K., Eichholtz T., Moolenaar W. H., Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins Cell 1989 59 1 45 54
2. Moolenaar W. H., van Meeteren L. A., Giepmans B. N. G., The ins and outs of lysophosphatidic acid signaling BioEssays 2004 26 8 870 881
3. Liu S., Murph M., Panupinthu N., Mills G. B., ATX-LPA receptor axis in inflammation and cancer Cell Cycle 2009 8 22 3695 3701
4. Tigyi G., Dyer D. L., Miledi R., Lysophosphatidic acid possesses dual action in cell proliferation Proceedings of the National Academy of Sciences of the United States of America 1994 91 5 1908 1912
5. Gaits F., Fourcade O., Le Balle F., Gueguen G., Gaig B., Gassama-Diagne A., Fauvel J., Salles J.-P., Mauco G., Simon M.-F., Chap H., Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis FEBS Letters 1997 410 1 54 58
6. Pages C., Girard A., Jeanneton O., Barbe P., Wolf C., Lafontan M., Valet P., Saulnier-Blache J. S., LPA as a paracrine mediator of adipocyte growth and function Annals of the New York Academy of Sciences 2000 905 159 164
7. Sano T., Baker D., Virag T., Wada A., Yatomi Y., Kobayashi T., Igarashi Y., Tigyi G., Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood The Journal of Biological Chemistry 2002 277 24 21197 21206
8. Fukushima N., Chun J., The LPA receptors Prostaglandins and Other Lipid Mediators 2001 64 14 21 32
9. Imamura F., Horai T., Mukai M., Shinkai K., Sawada M., Akedo H., Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D Biochemical and Biophysical Research Communications 1993 193 2 497 503
10. Fishman D. A., Liu Y., Ellerbroek S. M., Stack M. S., Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells Cancer Research 2001 61 7 3194 3199
11. Zheng Y., Kong Y., Goetzl E. J., Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a matrigel model basement membrane The Journal of Immunology 2001 166 4 2317 2322
12. Gschwind A., Hart S., Fischer O. M., Ullrich A., TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells The EMBO Journal 2003 22 10 2411 2421
13. Mills G. B., Eder A., Fang X., Hasegawa Y., Mao M., Lu Y., Tanyi J., Tabassam F. H., Wiener J., Lapushin R., Yu S., Parrott J. A., Compton T., Tribley W., Fishman D., Stack M. S., Gaudette D., Jaffe R., Furui T., Aoki J., Erickson J. R., Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer Cancer Treatment and Research 2002 107 259 283
14. Xu Y., Xiao Y. J., Zhu K., Baudhuin L. M., Lu J., Hong G., Kim K. S., Cristina K. L., Song L., S Williams F., Elson P., Markman M., Belinson J., Unfolding the pathophysiological role of bioactive lysophospholipids Current Drug Targets. Immune, Endocrine Metabolic Disorders 2003 3 1 23 32
15. Roberts J. A., Searching for a biomarker for ovarian cancer JAMA 1998 280 8 739
16. Fang X., Gaudette D., Furui T., Mao M., Estrella V., Eder A., Pustilnik T., Sasagawa T., Lapushin R., Yu S., Jaffe R. B., Wiener J. R., Erickson J. R., Mills G. B., Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer Annals of the New York Academy of Sciences 2000 905 188 208
17. Kue P. F., Taub J. S., Harrington L. B., Polakiewicz R. D., Ullrich A., Daaka Y., Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells International Journal of Cancer 2002 102 6 572 579
18. Daaka Y., Mitogenic action of LPA in prostate Biochimica et Biophysica Acta 2002 1582 13 265 269
19. Kusama T., Mukai M., Ayaki M., Imamura F., Tatsuta M., Matsumoto Y., Nakamura H., Inoue M., Inhib1ition of lysophosphatidic acid-induced RhoA activation and tumor cell invasion by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors International Journal of Oncology 2003 23 4 1173 1178
20. Sasagawa T., Okita M., Murakami J., Kato T., Watanabe A., Abnormal serum lysophospholipids in multiple myeloma patients Lipids 1999 34 1 17 21
21. Xu Y., Shen Z., Wiper D. W., Wu M., Morton R. E., Elson P., Kennedy A. W., Belinson J., Markman M., Casey G., Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JAMA 1998 280 8 719 723
22. Black E. J., Clair T., Delrow J., Neiman P., Gillespie D. A. F., Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun Oncogene 2004 23 13 2357 2366
23. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., Arai H., Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 The Journal of Biological Chemistry 2004 279 17 17634 17639
24. Jourquin J., Yang N., Kam Y., Guess C., Quaranta V., Dispersal of epithelial cancer cell colonies by lysophosphatidic acid (LPA) Journal of Cellular Physiology 2006 206 2 337 346
25. Schenk S., Hintermann E., Bilban M., Koshikawa N., Hojilla C., Khokha R., Quaranta V., Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution Journal of Cell Biology 2003 161 1 197 209
26. Koshikawa N., Schenk S., Moeckel G., Sharabi A., Miyazaki K., Gardner H., Zent R., Quaranta V., Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology The FASEB Journal 2004 18 2 364 366
27. Jinnin M., Ihn H., Asano Y., Yamane K., Trojanowska M., Tamaki K., Tenascin-C upregulation by transforming growth factor- in human dermal fibroblasts involves Smad3, Sp1, and Ets1 Oncogene 2004 23 9 1656 1667
28. Denton C. P., Abraham D. J., Transforming growth factor- and connective tissue growth factor: key cytokines in scleroderma pathogenesis Current Opinion in Rheumatology 2001 13 6 505 511
29. Dennler S., Itoh S., Vivien D., Dijke P. T., Huet S., Gauthier J.-M., Direct binding of Smad3 and Smad4 to critical TGF -inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene The EMBO Journal 1998 17 11 3091 3100
30. McGillicuddy F. C., O'Toole D., Hickey J. A., Gallagher W. M., Dawson K. A., Keenan A. K., TGF- 1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells Vascular Pharmacology 2006 44 6 469 475
31. Chen M. M., Lam A., Abraham J. A., Schreiner G. F., Joly A. H., CTGF expression is induced by TGF- in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis Journal of Molecular and Cellular Cardiology 2000 32 10 1805 1819
32. Lee J. M., Dedhar S., Kalluri R., Thompson E. W., The epithelial-mesenchymal transition: new insights in signaling, development, and disease Journal of Cell Biology 2006 172 7 973 981
33. Thiery J. P., Acloque H., Huang R. Y. J., Nieto M. A., Epithelial-mesenchymal transitions in development and disease Cell 2009 139 5 871 890
34. Shi Y., Massague J., Mechanisms of TGF- signaling from cell membrane to the nucleus Cell 2003 113 6 685 700
35. Sauer B., Vogler R., Zimmermann K., Fujii M., Anzano M. B., Schfer-Korting M., Roberts A. B., Kleuser B., Lysophosphatidic acid interacts with transforming growth factor- signaling to mediate keratinocyte growth arrest and chemotaxis Journal of Investigative Dermatology 2004 123 5 840 849
36. Jeon E. S., Moon H. J., Lee M. J., Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells Stem Cells 2008 26 3 789 797
37. Carter W. G., Ryan M. C., Gahr P. J., Epiligrin, a new cell adhesion ligand for integrin 3 1 in epithelial basement membranes Cell 1991 65 4 599 610
38. Niessen C. M., Hogervorst F., Jaspars L. H., De Melker A. A., Delwel G. O., Hulsman E. H. M., Kuikman I., Sonnenberg A., The 6 4 integrin is a receptor for both laminin and kalinin Experimental Cell Research 1994 211 2 360 367
39. Amano S., Akutsu N., Ogura Y., Nishiyama T., Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids British Journal of Dermatology 2004 151 5 961 970
40. Sauer B., Vogler R., Zimmermann K., Lysophosphatidic acid interacts with transforming growth factor- signaling to mediate keratinocyte growth arrest and chemotaxis Journal of Investigative Dermatology 2004 123 5 840 849
41. Massagu J., TGF- signal transduction Annual Review of Biochemistry 1998 67 753 791
42. Zapatka M., Zboralski D., Radacz Y., Bckmann M., Arnold C., Schneck A., Hoppe S., Tannapfel A., Schmiegel W., Simon-Assmann P., Schwarte-Waldhoff I., Basement membrane component laminin-5 is a target of the tumor suppressor Smad4 Oncogene 2007 26 10 1417 1427
43. Hintermann E., Quaranta V., Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors Matrix Biology 2004 23 2 75 85
44. Borradori L., Chavanas S., Schaapveld R. Q. J., Gagnoux-Palacios L., Calafat J., Meneguzzi G., Sonnenberg A., Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesionreexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes Experimental Cell Research 1998 239 2 463 476
45. Jones J. C. R., Hopkinson S. B., Goldfinger L. E., Structure and assembly of hemidesmosomes BioEssays 1998 20 6 488 494
46. Hirako Y., Owaribe K., Hemidesmosomes and their unique transmembrane protein BP180 Microscopy Research and Technique 1998 43 3 207 217
47. Zhang K., Kramer R. H., Laminin 5 deposition promotes keratinocyte motility Experimental Cell Research 1996 227 2 309 322
48. Nguyen B. P., Ren X.-D., Schwartz M. A., Carter W. G., Ligation of integrin 3 1 by Laminin 5 at the wound edge activates Rho-dependent adhesion of leading keratinocytes on collagen The Journal of Biological Chemistry 2001 276 47 43860 43870
49. Salo S., Boutaud A., Hansen A. J., He L., Sun Y., Morales S., Venturini A., Martin P., Nokelainen P., Betsholtz C., Mathiasen I. S., Tryggvason K., Antibodies blocking adhesion and matrix binding domains of laminin-332 inhibit tumor growth and metastasis in vivo International Journal of Cancer 2009 125 8 1814 1825
50. Giannelli G., Bergamini C., Fransvea E., Sgarra C., Antonaci S., Laminin-5 with transforming growth factor- 1 induces epithelial to mesenchymal transition in hepatocellular carcinoma Gastroenterology 2005 129 5 1375 1383
51. Mills G. B., Moolenaar W. H., The emerging role of lysophosphatidic acid in cancer Nature Reviews Cancer 2003 3 8 582 591